 | Up a level |
Balke, M., Wunderlich, G., Brunn, A., Fink, G. R. and Lehmann, H. C. (2016). Chronic Inflammatory Demyelinating Polyneuropathy. Forschritte Neurol. Psychiatr., 84 (12). S. 756 - 769. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-3522
Brunn, A., Utermoehlen, O., Mihelcic, M., Sanchez-Ruiz, M., Carstov, M., Blau, T., Ustinova, I., Penfold, M., Montesinos-Rongen, M. and Deckert, M. (2013). Differential effects of CXCR4-CXCL12-and CXCR7-CXCL12-mediated immune reactions on murine P0(106-125)-induced experimental autoimmune neuritis. Neuropathol. Appl. Neurobiol., 39 (7). S. 772 - 788. HOBOKEN: WILEY. ISSN 1365-2990
Ceccon, G. S., Werner, J., Ruge, M., I, Goldbrunner, R., Celik, E., Baues, C., Deckert, M., Brunn, A., Buttner, R., Golla, H., Nogova, L., Schlamann, M., Kabbasch, C., Ruess, D., Hampl, J., Wollring, M., Bauer, E. K., Tscherpel, C., Fink, G. R., Langen, K. and Galldiks, N. (2022). Impact of FET PET on multidisciplinary neurooncological tumor board decisions in patients with brain tumors. Neuro-Oncology, 24. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Filipova, D., Walter, A., Gaspar, J., Brunn, A., Deckert, M., Sachinidis, A., Pfitzer, G. and Papadopoulos, S. (2017). Transcriptomic changes during skeletal muscle development in the presence and absence of the type 1 ryanodine receptor (RYR1). Acta Physiol., 219. S. 38 - 39. HOBOKEN: WILEY. ISSN 1748-1716
Filipova, D., Walter, A. M., Gasper, J. A., Brunn, A., Deckert, M., Sachinidis, A., Pfitzer, G. and Papadopoulos, S. (2016). Profound changes in the gene expression of skeletal muscle lacking the type 1 ryanodine receptor (RYR1). Acta Physiol., 216. HOBOKEN: WILEY-BLACKWELL. ISSN 1748-1716
Huber, C. A., Wunderlich, G., Brunn, A., Blau, T., Fink, G. R. and Lehmann, H. C. (2015). 25-year old Patient with anginal Symptoms during the muslim Fasting Month. Dtsch. Med. Wochenschr., 140 (3). S. 202 - 206. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413
Neugebauer, A., Herkenrath, P., Koerber, F., Simon, T., Brunn, A., Deckert, M. and Fricke, J. (2016). Strabologic and neuro-ophthamologic aspects of childhood cancer. Ophthalmologe, 113 (7). S. 557 - 568. NEW YORK: SPRINGER. ISSN 1433-0423
Ozretic, L., Blau, T., Brunn, A., Buettner, R. and Fries, J. (2016). Multiple organ involvement in IgG4-related disease, misidentified as medical insurance case of asbestosis, leads to sudden death by endocarditis. Virchows Arch., 469. S. S91 - 1. NEW YORK: SPRINGER. ISSN 1432-2307
Quaas, A., Waldschmidt, D., Alakus, H., Zander, T., Heydt, C., Goeser, T., Daheim, M., Kasper, P., Plum, P., Bruns, C., Brunn, A., Roth, W., Hartmann, N., Bunck, A., Schmidt, M., Goebel, H., Tharun, L., Buettner, R. and Merkelbach-Bruse, S. (2018). Therapy susceptible germline-related BRCA 1-mutation in a case of metastasized mixed adeno-neuroendocrine carcinoma (MANEC) of the small bowel. BMC Gastroenterol., 18. LONDON: BIOMED CENTRAL LTD. ISSN 1471-230X
Werner, J., Wolf, L., Tscherpel, C., Bauer, E. K., Wollring, M., Ceccon, G., Deckert, M., Brunn, A., Pappesch, R., Goldbrunner, R., Fink, G. R. and Galldiks, N. (2022). EFFICACY AND TOLERABILITY OF REGORAFENIB IN PRETREATED PATIENTS WITH PROGRESSIVE CNS GRADE 3 OR 4 GLIOMAS. Neuro-Oncology, 24. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Wunderlich, G., Abicht, A., Brunn, A., Daimagueler, H. -S., Schroeter, M., Fink, G. R., Lehmann, H. C. and Cirak, S. (2019). Congenitalmyasthenic syndromes in adulthood. Challenging, rare but treatable. Nervenarzt, 90 (2). S. 148 - 160. NEW YORK: SPRINGER. ISSN 1433-0407